Programme

Day 1, July 17, 2008

• • 8:45 - 9:00 Welcoming RemarksJosé M Mato
  • 9:00 - 9:30 Special Opening Lecture 1J. Rodés, General Director, Hospital Clinic Barcelona. Spain.
  • 09:30 - 12:45 Session 1. Mechanisms of ALPDChaired by: H. Tsukamoto & SC LuF. Tacke Germany. "Chemokines and immune cells in liver injury".B. Gao. USA. "Interleunkin-6/STAT3 and alcoholic liver disease".
  • Coffee break (10:45 - 11:00)
  • M.V. Apte. Australia. (pancreas)R.K. Rao. USA ."Disruption of Intestinal Epithelial Tight Junctions and Barrier Dysfunction in Alcoholic Endotoxemia".S. Shukla .USA."Emerging role of epigenetics in alcoholic liver damage".
  • 13:00 - 15:30 Poster Viewing Session (25 total) & Lunch
  • 15:30 - 18:30 Session 2. Cell Death and CancerChaired by: J.C. Fernández-Checa & N. KaplowitzM. Czaja .USA ."Differential regulation of liver injury by JNK1 and JNK2"N. Kaplowitz. USA. "Dealing with stress in alcoholic liver disease""A.M. Diehl. USA. "Role of Progenitors in Recovery from Fatty Liver Damage"A. Lugea (USA - ER stress in pancreas)J. Fernández-Checa (Spain, mitochondia in ALD)
  • 18:30 - 19:00 Special Lecture 2G. Kunos NIAAA Scientific Director. USA. "Endocannabinoids and Alcoholic Liver Disease".

Day 2, July 18, 2008

• • 8:45 - 9:00 Special Remarks Kenneth R. Warren USA.Deputy Director. NIAAA
  • 9:00 - 9:30 Special Lecture 3S. Friedman, Liver Diseases Division Chief, Mount Sinai School of Medicine
  • 09:30 - 12:45 Session 3. Clinical ResearchChaired by: C. McClain & M. Imawari (JSGE, Japan)S. Kendrick U.K. "Susceptibility to Alcoholic Liver Disease"M. Mitchell (U.S. - clinical ALD) "Treatment of Alcoholic Liver Disease. Who should be treated, how long should treatment be and which therapy is best."
  • Coffee break (10:45 - 11:00)
  • R. Sutton U.K. - "Alcohol and the pancreas: basic findings and clinical applications."ML. Martínez-Chantar Spain - "Steatohepatitis and S-Adenosylmethionine. The Affair That Never Ends."C. McClain. USA. "Cytokine Modulation in the Treatment of Alcoholic Liver Disease."
  • 13:00 - 15:30 Oral presentation of selected posters (6 at 10 min each) & LunchModerated by S. Radaeva and D. Xie
  • 15:30 - 18:30 Session 4. Biomarkers in ALPD and CirrhosisChaired by: S. Pandol & José M MatoM. Suematsu (Japan- Metabolomics)S. Devanshi. Australia. "Novel mechanisms & biomarkers in ALD"F. Marra (Italy - HSC in ALD)C. Logsdon .USA . "Discovery and Validation of Biomarkers for Pancreatic Disease"L. Beretta (USA, Proteomics in liver disease)
  • 18:30 - 19:00 Special Lecture 4J. Bosch, Director CIBERehd, Hospital Clinic Barcelona
  • 19:00 - 19:15 Poster AwardG. Esmat (Egypt)
  • 19:15 - 19:45Closing RemarksS. Zakhari USA. NIAAA
  • 21.00 – 23:00 Cocktail dinner